Altogen Biosystems is a global provider of transfection reagents
and quality services for pharmaceutical companies, laboratories, and researchers involved in biotechnology-related fields. Biology contract research products that are offered include assay development, 28-day generation of specific stably-transfected cell
lines, and other laboratory services like siRNA screening and ELISA assay development. For an AGS cell xenograft model, visit the Altogen Biosystems website.
AGS cells are derived from the gastric tissue of a 54-year-old female, and represent one of the major players in the field of genomics research in gastric cancer. The cells are suitable for preclinical xenografts , and are prime subjects for transfection experiments. AGS cells have been researched extensively for pharmaceutical applications of histone deacetylase inhibition in stalling the growth of gastric cancer. They can easily serve as recipients of transfected genomic material, such as siRNA, which can be used for library screenings and the development of gene therapies specific to gastric cancer.
Comments
Post a Comment